ATMPs Consulting Market Size is predicted to witness a 8.6% CAGR during the forecast period for 2025-2034.
Advanced therapy medical products (ATMPs) are human medicines based on genes, tissues, or cells. They provide new and novel therapeutic options for ailments and injuries. ATMPs primarily target diseases with significant unmet medical needs. The introduction of ATMPs has altered the pharmaceutical industry as well as the illness treatment landscape. Advanced Therapy Medicinal Products (ATMPs) consulting involves seeking guidance and expertise from professionals and firms with specialized knowledge in developing, regulating, and commercialising advanced therapy medicinal products. It has opened up new avenues for the treatment of incurable diseases and cancers. Another factor driving market revenue growth is an increase in ATMP R&D spending by pharmaceutical companies, biotechnology businesses, and research institutes.
However, the global ATMPs (Advanced Therapy Medicinal Products) consultancy market was significantly impacted by the COVID-19 pandemic. The pandemic disrupted global supply lines, reducing the availability of crucial components and materials required for ATMP production. As a result, companies developing these medicines faced supply chain issues.
The global ATMP Consulting Market is segmented on the basis of phase and type. Based on phase, the market is divided as early-stage development, clinical development, and commercialization. The market is segmented by type into gene therapy medicinal products, somatic cell medicinal products, and tissue-engineered medicinal products.
The gene therapy medicinal products category is expected to hold a major share of the global ATMP Consulting Market in 2022. This is due to increased genetic diseases such as muscular dystrophy, haemophilia, and cystic fibrosis. Gene therapy has the potential to heal many disorders by tackling the underlying genetic abnormalities that cause them. Similarly, the development of breakthrough gene editing tools such as CRISPR-Cas9 has significantly increased the growth of gene therapy income. These technologies enable accurate and efficient genome editing, which is likely to drive segment revenue growth.
The early-stage development segment is projected to grow rapidly in the global ATMP Consulting Market. The Advanced Therapy Medicinal Products (ATMPs) consultancy market is characterized by various dynamic aspects that influence the industry's growth and direction. ATMPs are in high demand due to their ability to treat diseases that were previously untreatable. Early-stage consultancy must assist customers in identifying market prospects and determining the commercial viability of their cures.
The North American global ATMP Consulting Market is expected to record the maximum market share in revenue in the near future. A favourable regulatory environment, successful product launches, and significant investments in research and development are the primary factors leading to the region's supremacy in the market for advanced therapeutic pharmaceutical products. Furthermore, the fast-expanding number of clinical studies in this innovative therapeutic modality in the United States supports regional growth. The Asia Pacific area has experienced considerable growth in investment and support for ATMP research and development. Governments, corporate investors, and multinational collaborations are all assisting in expanding ATMPs throughout the region.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 8.6% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Phase, By Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; South Korea; South East Asia |
|
Competitive Landscape |
Dark Horse Consulting, PharmaLex (Acquired by AmerisourceBergen), ProPharma Group, QbD Group (Michor Consulting/EUDRAC), Alacrita Life Science Consulting, Voisin Consulting Life Sciences (VCLS), Advanced Cell & Gene Therapy, Kinesys Consulting, Clarkston Consulting, Validant/DataRevive, Asphalion, and Putnam. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Advanced Therapy Medicinal Products (ATMPs) Consulting Market Snapshot
Chapter 4. Global Advanced Therapy Medicinal Products (ATMPs) Consulting Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Phase Estimates & Trend Analysis
5.1. By Phase, & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Phase:
5.2.1. Early-Stage Development
5.2.2. Clinical Development
5.2.3. Commercialization
Chapter 6. Market Segmentation 2: By Type Estimates & Trend Analysis
6.1. By Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Type:
6.2.1. Gene therapy medicinal products
6.2.2. Somatic cell medicinal products
6.2.3. Tissue-engineered medicinal products
Chapter 7. Advanced Therapy Medicinal Products (ATMPs) Consulting Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) estimates and forecasts By Phase, 2021-2034
7.1.2. North America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) estimates and forecasts By Type, 2021-2034
7.1.3. North America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
7.2. Europe
7.2.1. Europe Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Phase, 2021-2034
7.2.2. Europe Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Type, 2021-2034
7.2.3. Europe Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) by country, 2021-2034
7.3. Asia Pacific
7.3.1. Asia Pacific Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Phase, 2021-2034
7.3.2. Asia Pacific Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Type, 2021-2034
7.3.3. Asia Pacific Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) by country, 2021-2034
7.4. Latin America
7.4.1. Latin America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Phase, (US$ Million) 2021-2034
7.4.2. Latin America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
7.4.3. Latin America Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) by country, 2021-2034
7.5. Middle East & Africa
7.5.1. Middle East & Africa Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Phase, (US$ Million) 2021-2034
7.5.2. Middle East & Africa Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) By Type, (US$ Million) 2021-2034
7.5.3. Middle East & Africa Advanced Therapy Medicinal Products (ATMPs) Consulting Market revenue (US$ Million) by country, 2021-2034
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Dark Horse Consulting
8.2.2. PharmaLex (Acquired by AmerisourceBergen)
8.2.3. ProPharma Group
8.2.4. Clarkston Consulting
8.2.5. Alacrita Life Science Consulting
8.2.6. Kinesys Consulting
8.2.7. Voisin Consulting Life Sciences (VCLS)
8.2.8. QbD Group (Michor Consulting/EUDRAC)
8.2.9. Advanced Cell & Gene Therapy
8.2.10. Validant/DataRevive
8.2.11. Asphalion
8.2.12. Putnam
8.2.13. Other Players
ATMPs Consulting Market By Phase-
ATMPs Consulting Market By Type-
ATMPs Consulting Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
